Savara Presents New Data From the Phase 3 IMPALA-2 Clinical Trial of Molgramostim Inhalation Solution (Molgramostim) in Patients With Autoimmune Pulmonary Alveolar Proteinosis (aPAP) at the European ...

Respiratory Bronchiolitis-Interstitial Lung Disease The natural history and outcome of RB-ILD have not been systematically evaluated. This limited case series presents long-term outcome data. Experts ...